Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering
Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering
New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
- Sichenzia Ross Ference 合伙人 Andrew M.J. Bernstein 的 CLE 在大陪审团实践中被选为 NYSBA 视频重播系列 - September 9, 2021
- Sichenzia Ross Ference LLP 代表 A.G.P./ Alliance Global Partners 作为配售代理完成 ShiftPixy, Inc. 1200 万美元的私募。 - September 9, 2021
- Document Security Systems, Inc. 从 Alset EHome International, Inc. 获得 1500 万美元的投资。 - September 8, 2021